In vivo voltammetry in the suprachiasmatic nucleus of the rat: Effects of RU24969, methiothepin and ketanserin

This publication has 16 references indexed in Scilit:

• The 5‐HT₁ receptor agonist RU‐24969 decreases 5‐hydroxytryptamine (5‐HT) release and metabolism in the rat frontal cortex in vitro and in vivo
  British Journal of Pharmacology, 1985
• Negative feedback control of serotonin release in vivo: Comparison of 5-hydroxyindolacetic acid levels measured by voltammetry in conscious rats and by biochemical techniques
  Neuroscience, 1983
• Differential pulse voltammetry in vivo - evidence that uric acid contributes to the indole oxidation peak
  Neuroscience Letters, 1983
• Voltammetric measurements of 5-hydroxyindole compounds in the suprachiasmatic nuclei: Circadian fluctuations
  Brain Research, 1983
• Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
• Further evidence for negative feedback control of serotonin release in the central nervous system
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors
  Life Sciences, 1981
• Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole)
  European Journal of Pharmacology, 1980
• An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat
  Journal of Comparative Neurology, 1978
• CParticipation of Serotonin in the Phasic Release of LH. I. Evidence from Pharmacological Experiments
  Endocrinology, 1976